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Purpose. To estimate the prevalence of glaucoma and costs associated with glaucoma care in South Korea between 2008 and 2013
using the Korean national claims database. Design. Retrospective cross-sectional study from a national claims database. Methods.
Patients who were diagnosed with glaucoma between 2008 and 2013 were retrospectively identified in the national claims database
using glaucoma diagnostic codes. For each year, the prevalence of glaucoma and direct medical costs associated with glaucoma
care were estimated. Result. The prevalence of glaucoma in patients ≥40 years of age increased from 0.79% in 2008 to 1.05% in 2013.
The number of patients with glaucoma increased by 54% between 2008 and 2013 (9% average annual increase). The prevalence of
glaucoma increased with age and was higher in males than in females. The cost to care for glaucoma patients increased from $16.5
million in 2008 to $29.2 million in 2013, which translated into an 81% increase over the 6 years examined (12.7% average annual
increase). Conclusion. The estimated prevalence and socioeconomic burden of glaucoma have steadily increased each year in South
Korea. Nevertheless, many glaucoma patients remain undiagnosed in the present study using national claims database.
1. Introduction
Glaucoma is a chronic eye disease that results in irreversible
optic nerve damage, which causes severe vision loss and
blindness. It is the second leading cause of blindness world-
wide and one of the leading causes of irreversible blindness
[1]. The estimated number of people around the world with
glaucoma was 64.3 million in 2013, and this number is
expected to increase to 111.8 million in 2040. The increasing
trend in the number of patients with glaucoma will continue
because of increased life expectancy. In recently published
systematic reviews, the glaucoma prevalence in subjects >40
years of age was estimated to be 3.54% (95% confidence
interval [CI]: 2.09–5.82) globally and 3.40% (95% CI: 2.26–
5.02) in Asia [2].
Most studies examining the prevalence of glaucoma have
been population-based, but these may be limited in determi-
ning glaucoma prevalence in real world because of differences
in setting of glaucoma diagnosis between clinical practice and
population-based studies. In additional, population-based
studies varied widely in terms of the eye examination meth-
ods and case definitions used [3].
Korean National Health Insurance (NHI) covers 50 mil-
lion people in South Korea, which represents approximately
97% of the Korean population. Therefore, we may be able to
use this database to obtain accurate statistics on glaucoma
in South Korea. These national claims database provides
unique real-world data froma large, complete, and unselected
population, providing important information about all types
of glaucoma disease [3].
In the current study, we estimated the prevalence of
glaucoma between 2008 and 2013 in Korea using the national
health claims database.This prevalencewas then compared to
estimates made with previous population-based studies. The
direct economic burden of glaucoma in Korea from 2008 to
2013 was also investigated.
2. Materials and Methods
All study conduct adhered to the tenets of the Declara-
tion of Helsinki. The Institutional Review Board of Yonsei
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UniversityHealth Systemdetermined that this study qualified
for exempt status (IRB permit number: 2014-2520-001).
We used data that was recorded in the national health
claims database between 2008 and 2013. Data were obtained
from the Health Insurance Review and Assessment (HIRA)
service of Korea (http://www.hira.or.kr/), which provided
deidentified data for this study. The HIRA is a governmental
agency overseen by the Korean Ministry of Health and
Welfare that examines and evaluates medical expenses of
all citizens (approximately 50 million people; 96.6% of the
population) covered by Korean NHI, the compulsory social
insurance, and Medical Aid (approximately 3.4% of the
population). The HIRA database contains payment records
from all medical facilities in South Korea and includes
information from 5-6 million inpatient visits each year at
approximately 1,100 hospitals and 25,000 private clinics [4].
The database contains data on diagnoses, procedures, pre-
scriptions, demographics, and direct medical costs. The
HIRA database manages claims using the sixth edition of the
Korean Classification of Disease (KCD-6), which is similar to
the International Classification of Disease (ICD-10) system.
The diagnostic codes for glaucoma are H40 (glaucoma) and
H42 (glaucoma in other diseases classified elsewhere). The
H40 code family includes diagnoses of glaucoma suspect (or
ocular hypertension [OHT], H400), open angle glaucoma
(OAG, H401, including normal tension glaucoma [NTG]
and primary open angle glaucoma [POAG]), angle closure
glaucoma (ACG, H402), secondary glaucoma (H403–406),
other glaucoma (H408), and unspecified glaucoma (H409).
The H42 code family includes diagnoses of glaucoma related
to endocrine, nutritional, and metabolic diseases (H420).
Surgical codes used to identify patients with glaucoma were
those for nonpenetrating filtering surgery (S5040), iridotomy
(S5041), filtering surgery (S5042), trabeculectomy (S5043),
cyclophotocoagulation (S5044), cyclocryosurgery for glau-
coma (S4055), trabeculotomy (S4057), sinusotomy (S4058),
and glaucoma implant surgery (S5049).
Data from the HIRA database were used to estimate the
size of the glaucoma population in South Korea. From all
payment requests between 2008 and 2013, we extracted all
requests for inpatient and outpatient services for patients
>40 years old whose main or secondary cause for the visit
was documented with an H40 or H42 KCD diagnosis code.
Patients that were given an H400 diagnosis code (glaucoma
suspect or OHT) were excluded from glaucoma prevalence
estimations.
For the calculation of glaucoma care cost, we applied the
annual KRW- (KoreanWon-) USD (US dollar) exchange rate
of each year and current KRW for each year was converted
to constant KRW (2013) using an annual inflation rate of 3%
(average increase in consumer price index over 6-year period
in South Korea). In the glaucoma care cost, all payment
requests for glaucoma diagnosis code were included such as
diagnostic test, procedure, and prescriptions.
The annual prevalence of glaucoma was calculated as
the number of people who were diagnosed with glaucoma
divided by the number of people that received NHI coverage
that year. The prevalence of glaucoma was based on patients
>40 years of age and was examined by age and sex. The 95%
CI of the prevalence rate was estimated based on a Poisson
distribution. Linear trend analyses were performed using
Mantel-Haenszel tests. All statistical analyseswere performed
using SPSS statistical software (ver. 19.0; SPSS, Inc., Chicago,
IL, USA). Statistical significance was defined as a 𝑃 value of
<0.05.
3. Results
Among the general population that was at least 40 years old
in South Korea, about 30% visited an ophthalmologist at least
once a year. This totaled approximately 7.0 million people in
2008 and 9.6 million in 2013. The numbers of patients with
glaucoma increased by approximately 9% each year (54.15%
increase between 2008 and 2013) and in 2013, more than
270,000 Koreans visited the hospital for glaucoma. The total
cost of glaucoma care in 2013 was over $29.8 million (USD)
and increased by approximately 81% between 2008 and 2013.
The cost of glaucoma care per person per year increased
from approximately $93.6 in 2008 to $110 in 2013 (Table 1).
The estimated prevalence of glaucoma had a significantly
increasing trend between 2008 and 2013 (0.796% in 2008,
0.835% in 2009, 0.883% in 2010, 0.979% in 2011, 1.006% in
2012, and 1.056% in 2013, 𝑃 < 0.001, Mantel-Haenszel test for
linear trend, Table 2). The estimated prevalence of glaucoma
suspects was 0.678% in 2008, 0.738% in 2009, 0.814% in
2010, 1.041% in 2011, 1.136% in 2012, and 1.206% in 2013. The
prevalence of glaucoma among people who visited an eye
clinic was 2.53% in 2008, 2.53% in 2009, 2.49% in 2010, 2.65%
in 2011, 2.71% in 2012, and 2.82% in 2013 (Table 1).
The most common glaucoma subtype was OAG, which
accounted for 56–62% of all glaucoma cases. The prevalence
of OAG, including NTG, was 0.459% (57.6% OAG) in 2008,
0.475% (56.9% OAG) in 2009, 0.497% (56.3% OAG) in 2010,
0.574% (58.6% OAG) in 2011, 0.606% (60.2% OAG) in 2012,
and 0.651% (61.6% OAG) in 2013. The proportion of patients
with ACG was 8–12%. The prevalence of ACG was 0.093%
(11.7% ACG), in 2008, 0.095% (11.4% ACG) in 2009, 0.1%
(11.3% ACG) in 2010, 0.095% (9.7% ACG) in 2011, 0.090%
(8.9% ACG) in 2012, and 0.090% (8.6% ACG) in 2013. The
OAG/ACG ratio was 4.94 in 2008, 5.00 in 2009, 5.00 in 2010,
6.04 in 2011, 6.75 in 2012, and 7.21 in 2013 (Table 2).
The prevalence of glaucoma increased with age. In 2013,
the glaucoma prevalence was 2.35% in subjects >80 years
old, 2.68% in subjects 70–79 years old, 1.66% in subjects 60–
69 years old, 0.70% in subjects 50–59 years old, and 0.35%
in subjects 40–49 years old. The prevalence of glaucoma
increased annually in each age group but was significantly
higher in older age groups (>60 years) than in younger ones
(Figure 1). After adjusting for gender, the odds ratio (OR)
of developing glaucoma was 1.616–1.759 with each decade
increase in age (Table 3). Glaucoma prevalence was higher
in males than in females during the time period examined
(Table 2). After adjusting for age, males were more likely to
have glaucoma than females (OR: 1.131–1.300, Table 3).
The total number and cost of glaucoma surgeries
increased annually, with 9773 glaucoma surgeries performed
in 2009, 9541 surgeries performed in 2010, 10,061 surgeries
performed in 2011, 10,912 surgeries performed in 2012, and
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Table 1: Glaucoma prevalence and glaucoma care costs between 2008 and 2013 in Koreans over 40 years of age.
2008 2009 2010 2011 2012 2013
Total population 22,092,004 22,835,230 23,555,512 24,315,896 24,988,953 25,678,881
Population visiting eye clinic 6,958,082 7,547,494 8,360,447 8,984,627 9,284,879 9,615,033
Number of glaucoma patients (%
glaucoma patients) 175,899 (2.53) 190,651 (2.53) 207,986 (2.49) 238,124 (2.65) 251,468 (2.71) 271,141 (2.82)
Male 86,534 93,940 103,066 117,578 123,814 133,914
Female 89,365 96,711 104,920 120,546 127,654 137,227
Glaucoma care costs (millions) $16.5 $19.3 $21.7 $22.9 $27.2 $29.8
Annual glaucoma care costs per person $93.6 $101.1 $104.3 $96.2 $108.0 $110.0
Results based upon data from the national claims database. The 2008–2013 Glaucoma care cost in 2013 constant dollars, using 3% average annual inflation rate
and applying the annual KRW/USD exchange rate of each year.
Table 2: Estimated prevalence (%) of glaucoma in Koreans over 40 years of age.
2008 2009 2010 2011 2012 2013
OAG (95% CI) 0.46(0.456–0.462)
0.48
(0.473–0.478)
0.50
(0.494–0.500)
0.57
(0.570–0.577)
0.61
(0.603–0.609)
0.65
(0.648–0.654)
ACG (95% CI) 0.093(0.092–0.094)
0.095
(0.094–0.096)
0.100
(0.099–0.101)
0.095
(0.094–0.096)
0.090
(0.090–0.091)
0.090
(0.089–0.091)
Overall (95% CI) 0.80(0.793–0.800)
0.83
(0.831–0.839)
0.88
(0.879–0.887)
0.98
(0.975–0.983)
1.01
(1.002–1.010)
1.06
(1.052–1.060)
Overall (male/female) 0.82/0.78 0.86/0.82 0.91/0.86 1.00/0.96 1.03/0.99 1.08/1.03
Proportion of OAG 57.6% 56.9% 56.3% 58.6% 60.2% 61.7%
Proportion of ACG 11.7% 11.4% 11.3% 9.7% 8.9% 8.6%
OAG/ACG ratio 4.94 5.00 5.00 6.04 6.75 7.21
Data obtained from the national claims database. OAG = open angle glaucoma, ACG = angle closure glaucoma, and CI = confidence interval.
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Figure 1: Prevalence of glaucoma in each age group.The prevalence
of glaucoma significantly increased with age in Korean adults. The
trend of increasing prevalence was statistically significant in older
(>60 years) groups.
12,502 surgeries performed in 2013. The most common type
of glaucoma surgery performed (including laser procedures)
was iridotomy, which accounted for 54.9% of surgeries in
2009, 55.4% of surgeries in 2010, 54.4% of surgeries in 2011,
53.2% of surgeries in 2012, and 49.6% of surgeries in 2013.
Trabeculectomy was the next most common surgery and
accounted for 23.6% of surgeries in 2009, 22.6% of surgeries
in 2010, 24.7% of surgeries in 2011, 28.1% of surgeries in
2012, and 32.1% of surgeries in 2013. The third most common
surgery was glaucoma implant surgery, which accounted for
8.5% of surgeries in 2009, 9.9% of surgeries in 2010, 9.2%
of surgeries in 2011, 9.1% of surgeries in 2012, and 8.1% of
surgeries in 2013. The proportion of iridotomies decreased
over time, while that of trabeculectomies increased each year.
The cost for all glaucoma surgeries reached approximately
$2.88 million in 2013 and the proportion of total glaucoma
care costs thatwere related to glaucoma surgeries significantly
decreased from 11.36% in 2009 to 9.14% in 2013 (Figure 2,
Table 4).
4. Discussion
We assessed the estimated prevalence of glaucoma and the
trend in glaucoma-associated figures in Korea over 6 years
(2008 to 2013) using the national claims database. Advantages
of using the national claims database over population surveys
include its very large sample size and its more representa-
tive diagnostic patterns. Korean NHI is compulsory social
insurance that covers 50 million Korean people (approxi-
mately 97% of population). It is more powerful than any
other national claims database. Additionally, claims data are
not regional, but nationwide, which provide more accurate
4 Journal of Ophthalmology
Table 3: Effect of age and gender on the prevalence of glaucoma.
Univariate Multivariate
Odds ratio (95% CI) 𝑃 value Odds ratio (95% CI) 𝑃 value
2008
Age, per decade increase 1.664 (1.658–1.670) <0.001 1.616 (1.610–1.622) <0.001
Sex <0.001 <0.001
Female 1.000 (reference) 1.000 (reference)
Male 1.047 (1.037–1.056) 1.131 (1.120–1.142)
2009
Age, per decade increase 1.683 (1.678–1.689) <0.001 1.759 (1.753–1.766) <0.001
Sex <0.001 <0.001
Female 1.000 (reference) 1.000 (reference)
Male 1.048 (1.038–1.057) 1.300 (1.288–1.311)
2010
Age, per decade increase 1.704 (1.698–1.709) <0.001 1.723 (1.717–1.729) <0.001
Sex <0.001 <0.001
Female 1 (reference) 1.000 (reference)
Male 1.058 (1.048–1.067) 1.237 (1.226–1.248)
2011
Age, per decade increase 1.719 (1.714–1.725) <0.001 1.738 (1.733–1.743) <0.001
Sex <0.001 <0.001
Female 1.000 (reference) 1.000 (reference)
Male 1.048 (1.039–1.056) 1.228 (1.218–1.238)
2012
Age, per decade increase 1.712 (1.707–1.717) <0.001 1.729 (1.724–1.735) <0.001
Sex <0.001 <0.001
Female 1.000 (reference) 1.000 (reference)
Male 1.040 (1.032–1.049) 1.214 (1.204–1.223)
2013
Age, per decade increase 1.730 (1.725–1.735) <0.001 1.748 (1.743–1.753) <0.001
Sex <0.001 <0.001
Female 1.000 (reference) 1.000 (reference)
Male 1.046 (1.039–1.054) 1.223 (1.214–1.232)
CI = confidence interval.
Table 4: The cost and number of glaucoma surgeries (including laser procedures) in Korea between 2009 and 2013 (2008 database was
unavailable).
2009 2010 2011 2012 2013
Cost of glaucoma surgeries (US$) 2,226,234 2,148,179 2,211,149 2,414,895 2,847,254
Iridectomy (%) 5,362 (54.9%) 5,288 (55.4%) 5,469 (54.4%) 5,809 (53.2%) 6,202 (49.6%)
Trabeculectomy (%) 2,301 (23.4%) 2,152 (22.6%) 2,489 (24.7%) 3,067 (28.1%) 4,013 (32.1%)
Glaucoma implant surgery (%) 831 (8.5%) 946 (9.9%) 928 (9.2%) 991 (9.1%) 1,009 (8.1%)
Iris, ciliary photocoagulation 822 668 779 614 698
Trabeculotomy 236 279 206 205 365
Ciliary body cryotherapy 96 86 93 95 75
Nonpenetrating filtering surgery 63 47 31 38 58
Other filtering surgery 57 73 64 89 80
Total number of surgeries 9,773 9,541 10,061 10,912 12,502
Results based on data from the national claims database.
estimates of disease prevalence in Korea. Because claims data
are longitudinal, they can also be used to recognize trends
over time in disease prevalence.
In the present study, the number of patients with glau-
coma significantly increased each year (54% increase between
2008 and 2013). Tham et al. [2] estimated that the number
of people worldwide with glaucoma will increase over 2013
levels by 18.3% in 2020 and by 74% in 2040, largely because
of an increased life expectancy. In our study, the proportion
of elderly patients (>60 years) in the Korean NHI database
gradually increased from 14.28% in 2008 to 16.88% in 2013.
This was not enough to explain the marked increase we
observed in the incidence of glaucoma, which was higher
than in previous studies [1, 2].
It is possible that the dramatic increase in people with
glaucoma observed here does not reflect an increase in
glaucoma prevalence. Rather, the glaucoma increase may
reflect improvements in glaucoma detection, whichmay have
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Table 5: Estimated prevalence of undetected glaucoma.
2008 2009 2010 2011 2012 2013
Population visiting an eye clinic 6,958,082 7,547,494 8,360,447 8,984,627 9,284,879 9,615,033
Number of patients diagnosed with glaucoma
(from national claims database) 175,899 190,651 207,986 238,124 251,468 271,141
Estimated number of glaucoma patientsa 773,220 799,233 824,443 851,056 874,613 898,761
Estimated number of patients with undetected
glaucomab 529,687 535,071 531,827 536,594 549,643 562,235
Proportion of patients with undetected glaucoma 68.5% 66.9% 64.5% 63.0% 62.8% 62.5%
Results based upon data from the national claims database. aEstimated value based on the 3.5% glaucoma prevalence reported in a systematic review [2] (i.e.,
total population × 0.035). bEstimated value based on the population who had not been to an eye clinic within a year (i.e., 0.35 × [total population − population
who visited an eye clinic within one year]).
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Figure 2: Trends in glaucoma surgery costs and number of proce-
dures in Korea.The number of glaucoma surgeries performed (black
squares) increased annually, but the proportion of total glaucoma
care costs associated with glaucoma surgery (gray bars) decreased
annually. Both trends were statistically significant.
occurred for several reasons. First, access to eye health-
care improved during the study period. Between 2008 and
2013, the number of eye clinics in Korea increased by 9%
(1301 clinics in 2008 and 1418 clinics in 2013) and the
number of ophthalmologists increased by 23% (determined
from NHI database). The increase in refractive and cataract
surgery also led to improvements in glaucoma detection in
Korea. In almost all eye clinics, preoperative ophthalmic
examinations include fundus and optic nerve examinations.
Therefore, the higher surgical rate increased the chance of
identifying patients with asymptomatic glaucoma. Second,
the national health education and health promotion pro-
gram has increased interest and awareness about health
and disease in Korea. Additionally, the development of the
internet and multimedia has improved disease awareness
among the general population. Informing the community
about glaucoma is an important step in promoting preventive
ophthalmic care [5]. In Korea, news stories related to glau-
coma significantly increased from 533 stories in 2008 to 1490
stories in 2013 (data obtained from the internet portal site,
NAVER [http://www.naver.com/]). Additionally, the Korean
national health check-up program does not include a fundus
examination, butmost hospitals have implemented programs
that include fundus examinations as part of medical check-
ups. Therefore, more fundus examinations were performed
as the population received more recent medical check-ups,
which subsequently resulted in more glaucoma diagnoses.
Several studies have reported the prevalence of glaucoma
in East Asia and in South Korea. Kim et al. [6] found that the
prevalence of glaucoma in rural populations over 50 years of
age was 3.4% (95% CI: 2.1%–4.8%). The Namil Study Group
performed a population-based survey of glaucoma in a rural
area of central South Korea and found that the prevalence
of glaucoma was 4.5% [7]. Similarly, the Tajimi Study Report
[8, 9] reported a glaucoma prevalence of 5.0% (95%CI: 4.2%–
5.8%) in central Japan and a systematic review reported a
glaucoma prevalence of 2.26%–5.02% in Asia [2]. Although
the prevalence of glaucoma among the population that visited
an eye clinic was similar to other reports (2.53–2.82%),
we found a much lower estimated prevalence of glaucoma
among the total population (1.06%), as well as a lower
POAG prevalence (0.65%), in 2013 based on the national
claims database. We speculate that our glaucoma prevalence
was underestimated, even though disease incidence can be
overestimated when using national claims data [10, 11].
Other population-based studies found a substantially
higher prevalence of glaucoma than reported in the current
study. Our study may have underestimated glaucoma preva-
lence for several reasons. First, the most common type of
glaucoma is chronic asymptomatic disease. Because glau-
coma can remain asymptomatic until it becomes severe, there
is a high likelihood that the number of affected individuals
is much higher than the number known to have the disease
[12, 13]. In fact, several studies have reported a very low
awareness of and knowledge about glaucoma in the general
population [5, 14], with only 10–50% of people with glaucoma
aware that they have the disease [12, 13, 15–17]. Additionally,
the high rate of undiagnosed POAG (92.7%) was shown in a
population-based study in Korea [18]. When we estimate the
number of patients with glaucoma using the 3.5% glaucoma
prevalence reported in a systematic review [2], the proportion
of undetected patients with glaucoma in our study was
about 70% (Table 5). Only patients already diagnosed with
glaucoma were included in our analyses. Therefore, the
chronic characteristics of glaucoma may be well reflected.
Moreover, our underestimated prevalence of glaucoma may
have resulted from the high proportion of NTG in Korea.
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Although elevated intraocular pressure (IOP) is the hallmark
sign and a well-known risk factor for glaucoma, several
population-based studies found that IOP was <22mmHg in
25–50% of glaucoma patients [19]. In fact, 77% of patients
with OAG in Korea have NTG [18]. Unfortunately, NTG
cannot be detected through tonometry. Therefore, it is more
difficult to detect than OAG with ocular hypertension.
Even though our estimated prevalence of diagnosed glau-
coma was lower than in other population-based studies, the
features of glaucoma prevalence were similar. In agreement
with previous studies [2, 3, 18, 20], our multivariate analysis
revealed a gender-adjusted OR for glaucoma of 1.7 with
each decade increase in age. Additionally, glaucoma was
more prevalent in males than in females after adjusting for
age (OR: 1.1–1.3). Some controversy remains about whether
gender affects glaucoma prevalence, but previous studies
conducted in Korea have also shown a higher prevalence in
males [6, 20]. In our multivariate analysis model, age had a
more significant effect on glaucoma prevalence than gender
(Table 3). Additionally, the fact thatOAGandACGaccounted
for the highest and second highest proportion of glaucoma
cases, respectively, is consistent with other studies [2, 20, 21].
We found that the OAG/ACG ratio was 4.9–7.2 (Table 2),
which is also similar to other studies conducted on East Asian
populations [7, 21].
Both the number of glaucoma cases and the number of
glaucoma surgeries showed an increasing trend over time.
Interestingly, the proportion of money spent on glaucoma
surgeries decreased annually (Figure 2). This may have been
caused by a progressive increase in antiglaucoma medication
usage.
Our study had several imitations. First, people with
undiagnosed glaucoma were not included in our estimates of
glaucoma prevalence, which may have resulted in an under-
estimated prevalence. Additionally, national claims data do
not always match hospital chart records. It has been shown
that national claims data and hospital records only have a 70–
80% concordance rate [22]. Second, although data from the
national claims database better represents the clinical situa-
tion than data frompopulation-based studies, inconsistencies
between clinicians in disease diagnostic criteria and practical
patterns may have influenced our results, especially for angle
closure glaucoma. Finally, we did not assess risk factors
for glaucoma (e.g., myopia, elevated IOP, and comorbid
conditions), which would require further investigation with
additional national claims data.
In conclusion, the prevalence and socioeconomic burden
of glaucoma are increasing annually. Nevertheless, based on
national claims data, we speculate that many patients with
glaucoma remain undiagnosed in Korea. Ways to identify
these patients are needed so that the disease can be managed
to minimize vision loss in glaucoma patients with a long life
expectancy.
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